OrbiMed
New York, USA · Seed → Growth
Their stated focus (public profile)
OrbiMed is a global healthcare-focused investment firm managing approximately $20 billion across public and private company investments. It invests across the full healthcare spectrum—biopharmaceuticals, medical devices, diagnostics, digital health, and healthcare services—from seed-stage venture capital through large publicly-traded companies. The firm operates three strategies: private equity (venture and growth), private credit/royalty (structured debt and royalty monetization), and public equity (long/short and closed-end funds). OrbiMed emphasizes driving innovation, addressing unmet medical needs, and improving patient outcomes globally.
Stages: Seed → Growth
Sectors: Life sciences, Medtech, Healthtech
On file: 21 companies on record
Website: orbimed.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.